Ophthalmic Devices

Ophthalmic Devices Market Outlook

The global ophthalmic devices market is anticipated to reach approximately USD 60 billion by 2035, growing at a compound annual growth rate (CAGR) of around 6.5% from 2025 to 2035. This growth is primarily driven by the increasing prevalence of eye-related disorders, advancing technology in ophthalmic devices, a rapidly aging population, and rising awareness regarding eye health. Furthermore, innovations in surgical techniques and diagnostic technologies have significantly contributed to market expansion. The demand for vision care devices is also expected to rise as the awareness of eye health and visual impairment increases, coupled with the growing trend of preventive healthcare. The emergence of telemedicine and online consultations has played a pivotal role in expanding the market as well, making eye care more accessible to the general population.

Growth Factor of the Market

The ophthalmic devices market is experiencing significant growth due to various factors that cater to the needs of the population suffering from vision disorders. One of the key growth factors is the increasing prevalence of chronic eye diseases such as cataracts, glaucoma, and age-related macular degeneration. The rise in these conditions is largely attributed to aging demographics, as older individuals are more susceptible to these disorders. Moreover, technological advancements in ophthalmic devices, including minimally invasive surgical techniques and innovative diagnostic equipment, are propelling market growth by improving patient outcomes and reducing recovery times. Increased investments in research and development within the ophthalmic sector also contribute to product innovation and market expansion. Additionally, the growing trend of regular eye check-ups and preventive measures taken by individuals to maintain their eye health has further driven the demand for ophthalmic devices.

Key Highlights of the Market

• Significant growth in demand for innovative diagnostic and surgical devices.
• Increasing prevalence of eye diseases among the aging population.
• Technological advancements enhancing the efficacy of ophthalmic treatments.
• Expansion of healthcare infrastructure and improvement in healthcare expenditure.
• Increasing awareness about eye health among consumers.

By Product Type

Diagnostic Devices:

Diagnostic devices are crucial in the ophthalmic devices market as they facilitate early detection and effective management of eye diseases. These devices include tools such as tonometers, autorefractors, and optical coherence tomography (OCT) machines that aid in assessing ocular conditions and overall eye health. With advancements in technology, diagnostic devices have become more sophisticated, allowing for better imaging and accuracy in diagnostics. The rising demand for early diagnosis of vision disorders is driving the growth of this segment, particularly in clinical settings where timely intervention can significantly improve patient outcomes. The integration of artificial intelligence in these devices is further enhancing their capabilities, enabling healthcare professionals to make informed decisions about patient care.

Surgical Devices:

Surgical devices play a pivotal role in the treatment of various ocular conditions, with cataract surgery being one of the most common procedures performed worldwide. The surgical devices segment includes equipment such as phacoemulsification devices, laser surgical systems, and intraocular lens (IOL) implants. Recent advancements in surgical techniques, including minimally invasive procedures and the use of femtosecond lasers, have revolutionized this segment, resulting in faster recovery times and improved surgical outcomes. The increasing prevalence of cataracts and other refractive errors is expected to drive the demand for surgical devices, as more individuals seek corrective interventions. Moreover, ongoing innovations and the development of new surgical approaches are anticipated to further boost this market segment.

Vision Care Devices:

Vision care devices encompass a wide range of products designed to assist individuals in maintaining their eye health and vision. This segment includes eyeglasses, contact lenses, and low-vision aids. The growing awareness about eye health, coupled with an increase in myopia and presbyopia cases globally, has significantly contributed to the demand for vision care devices. Additionally, the trend of personalization in eyewear, such as customizable frames and advanced lens technologies, is driving innovation and growth in this segment. Furthermore, the rise of online sales platforms for eyewear is expanding accessibility and convenience for consumers, thus enhancing the overall market potential for vision care devices.

Other Devices:

The "Other Devices" category includes a variety of ophthalmic instruments and tools that do not fall under the primary classifications of diagnostic, surgical, or vision care devices. This segment consists of equipment used in eye surgeries, diagnostic imaging, and tools for eye examinations, including slit lamps and fundus cameras. These devices are essential for facilitating comprehensive eye care and are widely used in hospitals, clinics, and private practices. The ongoing advancements in these devices, such as improved imaging capabilities and enhanced user interfaces, are contributing to their growing adoption. As healthcare facilities continue to upgrade their equipment to provide better patient care, the demand for this segment is expected to increase steadily.

By Application

Cataract Surgery:

Cataract surgery is one of the most commonly performed surgical procedures globally, and the growing elderly population is a significant factor driving this trend. The increasing incidence of cataracts necessitates the use of advanced surgical devices and techniques, which has resulted in a burgeoning market for cataract surgery applications. Innovations such as phacoemulsification and femtosecond laser-assisted cataract surgery have transformed surgical practices, leading to shorter recovery times and improved visual outcomes. With the rise in awareness about eye health and advancements in surgical technology, more patients are seeking cataract surgeries, thereby contributing to the growth of this application segment.

Refractive Surgery:

Refractive surgery applications focus on correcting vision issues such as myopia, hyperopia, and astigmatism through procedures like LASIK and PRK. The demand for refractive surgery has surged as individuals increasingly seek alternatives to glasses and contact lenses for vision correction. The continuous evolution of refractive surgical techniques, coupled with the introduction of advanced laser technologies, has significantly improved patient satisfaction and safety. Furthermore, the growing acceptance of refractive surgeries and the increasing prevalence of refractive errors among younger populations are anticipated to fuel growth in this application segment, making it a pivotal area within the ophthalmic devices market.

Diagnostics & Monitoring:

Diagnostics and monitoring are critical applications within the ophthalmic devices market, focusing on early detection and ongoing management of eye diseases. The increasing prevalence of chronic eye conditions has amplified the demand for advanced diagnostic tools and monitoring devices that can provide timely and accurate information. Technologies like optical coherence tomography (OCT) and fundus photography are essential for diagnosing conditions such as diabetic retinopathy and glaucoma. As healthcare providers emphasize the importance of regular eye examinations and preventive care, the diagnostics and monitoring application segment is poised for substantial growth, driven by innovation and increasing awareness of eye health.

Others:

The "Others" category includes various applications that do not fit into the primary classifications but are essential for overall eye care. This segment encompasses treatments for conditions such as retinal disorders and corneal diseases, and utilizes devices such as retinal lasers and keratoplasty instruments. The growing awareness about the importance of comprehensive eye care, along with increasing incidences of retinal diseases, is driving the adoption of these applications. As healthcare systems evolve and prioritize eye health, the demand for diverse ophthalmic applications is expected to rise, promoting growth in this segment.

By End User

Hospitals:

Hospitals represent a significant end-user segment in the ophthalmic devices market, as they provide a wide range of eye care services, including diagnostics, surgeries, and treatment for various ocular conditions. As healthcare facilities continue to invest in advanced technologies and equipment, hospitals are increasingly adopting state-of-the-art ophthalmic devices to enhance patient care and outcomes. The growing prevalence of eye diseases, combined with the increasing patient population seeking treatment in hospitals, is driving the demand for ophthalmic devices within this segment. Moreover, the establishment of specialized eye care units and departments within hospitals is expected to further fuel market growth, as more patients seek comprehensive eye treatment in these facilities.

Specialty Clinics:

Specialty clinics focusing solely on eye care are becoming increasingly prominent in the ophthalmic devices market. These clinics provide specialized services such as advanced diagnostics, refractive surgery, and vision rehabilitation, attracting a large number of patients seeking tailored eye care solutions. With the growing demand for personalized treatment options and cutting-edge technology, specialty clinics are investing in the latest ophthalmic devices to ensure optimal patient care. Additionally, the rise of telehealth services has allowed specialty clinics to reach a broader patient base, further enhancing their market presence. As the focus on specialized eye care continues to grow, the demand for ophthalmic devices in this segment is expected to increase significantly.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) have emerged as a vital player in the ophthalmic devices market, providing patients with an alternative to traditional hospital-based surgical procedures. These centers specialize in outpatient eye surgeries, such as cataract and refractive surgeries, allowing patients to receive care without the need for overnight hospitalization. The increasing preference for minimally invasive procedures and the focus on reducing healthcare costs have contributed to the growth of ASCs in the ophthalmic sector. As more patients seek convenient and efficient surgical options, the demand for ophthalmic devices within ASCs is expected to rise significantly, making this segment a crucial area of growth in the market.

Others:

The "Others" category encompasses various end-user segments involved in ophthalmic care, including research institutions, academic centers, and optical retail outlets. Research institutions play a critical role in advancing ophthalmic technologies and developing innovative devices through clinical trials and studies. Academic centers contribute to the education and training of healthcare professionals, ensuring the effective use of ophthalmic devices in clinical practice. Additionally, optical retail outlets facilitate access to vision care devices such as eyeglasses and contact lenses, catering to consumers' eye care needs. As the focus on eye health continues to grow across all these segments, the demand for ophthalmic devices is expected to maintain a positive trajectory.

By Technology

Femtosecond:

Femtosecond laser technology has revolutionized the field of ophthalmology, particularly in refractive surgery and cataract procedures. This technology utilizes laser pulses of exceptionally short duration to precisely perform surgical procedures, ensuring minimal tissue damage and enhanced accuracy. Femtosecond lasers are commonly used in LASIK surgeries and cataract surgeries to create corneal flaps and perform lens fragmentation, respectively. The increasing adoption of femtosecond lasers is driven by their ability to improve surgical outcomes and reduce recovery times. As patients become increasingly aware of the benefits of advanced surgical techniques, the demand for femtosecond laser technology is expected to rise, bolstering its position in the ophthalmic devices market.

Excimer Lasers:

Excimer lasers are widely utilized in refractive surgeries to correct vision issues such as myopia, hyperopia, and astigmatism. These lasers work by emitting ultraviolet light to reshape the cornea, allowing for precise corrections without the need for incisions. The popularity of excimer lasers in LASIK procedures and other refractive surgeries has contributed significantly to the growth of this technology segment in the ophthalmic devices market. As more individuals seek alternatives to glasses and contact lenses, the demand for excimer laser technologies is expected to continue growing. Furthermore, advancements in laser technology and the introduction of new applications are anticipated to further enhance the market potential for excimer lasers.

Optical Coherence Tomography:

Optical coherence tomography (OCT) is a non-invasive imaging technology that has become an essential tool in the diagnosis and monitoring of various eye conditions, including glaucoma and age-related macular degeneration. OCT allows for high-resolution cross-sectional imaging of the retina, providing clinicians with valuable insights into the structure and function of ocular tissues. The growing prevalence of chronic eye diseases and the increasing demand for early diagnosis have driven the adoption of OCT in both hospital and clinical settings. As technological advancements continue to improve the capabilities of OCT devices, their application in ophthalmology is expected to expand, further contributing to the growth of this technology segment.

Others:

The "Others" category encompasses a variety of technologies used in ophthalmic devices that do not fall under the primary classifications. This segment includes traditional diagnostic instruments, surgical tools, and innovative technologies that aid in treating ocular conditions. Advances in imaging technologies, such as fundus photography and retinal imaging systems, are also included in this category. The ongoing development of new technologies and the introduction of portable diagnostic devices are expected to drive growth in this segment as healthcare professionals increasingly seek efficient and effective solutions for eye care. The diverse array of technologies available in the market enhances the overall potential for ophthalmic devices across different applications and segments.

By Region

The ophthalmic devices market is witnessing regional growth across various geographic areas, with North America leading the market due to the high prevalence of eye diseases and well-established healthcare infrastructure. The North American ophthalmic devices market is projected to account for over 40% of the global market share by 2035, driven by advancements in technology and increased healthcare spending. The United States is the largest contributor to the market in this region due to a rising aging population that is more prone to vision-related disorders. Additionally, the focus on innovative surgical procedures and diagnostic technologies, alongside the presence of key market players, is expected to sustain the growth momentum in North America.

Europe is also a significant market for ophthalmic devices, projected to grow at a CAGR of around 5% during the forecast period. The increasing awareness regarding eye health, coupled with advancements in technology and innovative treatment options, is expected to drive market growth in this region. Additionally, the aging population in countries such as Germany, France, and the United Kingdom is further propelling the demand for ophthalmic devices. The Asia Pacific region is anticipated to witness the fastest growth during the forecast period, fueled by factors such as increasing healthcare access, rising disposable incomes, and a growing population. Countries like China and India are expected to contribute significantly to the market expansion due to their large patient base and increasing healthcare investments.

Opportunities

The ophthalmic devices market presents numerous opportunities driven by the growing demand for advanced eye care solutions. One significant opportunity lies in the emerging markets, where rapid economic growth and urbanization are increasing access to healthcare services. As more individuals in developing regions seek eye care, there is a tremendous opportunity for market players to introduce innovative, cost-effective ophthalmic devices tailored to local needs. Furthermore, partnerships between healthcare providers and technology companies can facilitate the development of next-generation ophthalmic devices, enhancing diagnostic capabilities and treatment outcomes. The potential for telemedicine and remote monitoring solutions is also an area ripe for exploration, enabling patients to access eye care from the comfort of their homes, thus broadening the market reach.

Moreover, an increasing emphasis on research and development in ophthalmology creates opportunities for the introduction of cutting-edge technologies and devices. As the demand for personalized medicine rises, ophthalmic device manufacturers can focus on developing customized solutions that cater to individual patient needs. Advances in artificial intelligence and machine learning can be leveraged to enhance diagnostic accuracy and treatment planning, further propelling market growth. The rise of preventative care and routine eye examinations is another area of opportunity, encouraging healthcare providers to invest in state-of-the-art ophthalmic devices that facilitate early detection and intervention, thereby improving patient outcomes and driving overall market expansion.

Threats

The ophthalmic devices market faces several threats that could potentially hinder its growth trajectory. One major concern is the increasing competition from emerging players offering low-cost alternatives to established products. As more manufacturers enter the market, price competition may intensify, leading to reduced profit margins for existing companies. Additionally, regulatory challenges related to the approval of new ophthalmic devices can create barriers to market entry and slow down the introduction of innovative products. Stringent regulations and compliance requirements may deter some manufacturers from investing in new technologies, affecting overall market growth. Furthermore, economic fluctuations and uncertainties can impact healthcare spending, leading to reduced investments in ophthalmic devices.

Another significant threat is the potential for technology obsolescence, particularly as rapid advancements in medical technology continue to evolve. Manufacturers must continually innovate and adapt to stay competitive, which requires substantial research and development investments. Failure to keep pace with technological advancements can result in losing market share to more agile competitors. Additionally, the global supply chain disruption witnessed in recent years due to the pandemic has highlighted vulnerabilities in sourcing and production processes, potentially impacting the availability of ophthalmic devices in the market. Managing these threats effectively will be crucial for stakeholders in the ophthalmic devices market to maintain growth and sustainability.

Competitor Outlook

• Johnson & Johnson Vision Care
• Alcon Inc.
• Abbott Laboratories
• Bausch + Lomb
• Zeiss Group
• Hoya Corporation
• EssilorLuxottica
• Medtronic plc
• Topcon Corporation
• Shire plc
• CooperVision, Inc.
• Oculus Optikgerate GmbH
• Rayner Intraocular Lenses Limited
• Heidelberg Engineering GmbH
• Carl Zeiss AG

The competitive landscape of the ophthalmic devices market is characterized by the presence of numerous established players and emerging companies striving to capture market share. Key players are increasingly focusing on innovation and technological advancements to maintain their competitive edge and meet the evolving needs of healthcare professionals and patients. Collaborations, mergers, and acquisitions are common strategies adopted by companies to enhance their product portfolios and expand their market reach. For instance, Johnson & Johnson Vision Care is continuously investing in research and development to introduce next-generation surgical and vision care devices, thus positioning itself as a market leader in ophthalmic technologies. Similarly, Alcon Inc. has made significant strides in expanding its range of surgical devices and solutions, catering to the growing demand for cataract and refractive surgeries.

Bausch + Lomb, a prominent player in the ophthalmic industry, focuses on providing comprehensive eye care solutions, including surgical and vision care products. The company emphasizes product innovation and quality, which has allowed it to maintain a strong market presence. Additionally, the company has witnessed growth through strategic collaborations and partnerships with healthcare providers to enhance its offerings. Similarly, Abbott Laboratories has established itself as a key player in the diagnostics and surgical segments of ophthalmic devices, delivering advanced solutions that meet the needs of healthcare professionals and patients alike. The company's commitment to advancing ophthalmic care through innovative technologies allows it to stay competitive in the evolving market landscape.

Emerging companies are also making their mark in the ophthalmic devices market by introducing disruptive technologies and cost-effective solutions. For example, startups focusing on telemedicine and remote monitoring solutions are increasingly gaining traction as more patients seek convenient access to eye care. These companies are leveraging technology to enhance patient engagement and improve treatment outcomes, thereby contributing to the overall growth of the market. As the industry continues to evolve, it is expected that both established and emerging players will play a crucial role in shaping the future of ophthalmic devices, driving innovation, and improving overall patient care.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Shire plc
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Alcon Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Zeiss Group
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Bausch + Lomb
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Carl Zeiss AG
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Medtronic plc
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 EssilorLuxottica
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Hoya Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 CooperVision, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Topcon Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Abbott Laboratories
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Oculus Optikgerate GmbH
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Heidelberg Engineering GmbH
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Johnson & Johnson Vision Care
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Rayner Intraocular Lenses Limited
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Ophthalmic Devices Market, By End User
    • 6.1.1 Hospitals
    • 6.1.2 Specialty Clinics
    • 6.1.3 Ambulatory Surgical Centers
    • 6.1.4 Others
  • 6.2 Ophthalmic Devices Market, By Technology
    • 6.2.1 Femtosecond
    • 6.2.2 Excimer Lasers
    • 6.2.3 Optical Coherence Tomography
    • 6.2.4 Others
  • 6.3 Ophthalmic Devices Market, By Application
    • 6.3.1 Cataract Surgery
    • 6.3.2 Refractive Surgery
    • 6.3.3 Diagnostics & Monitoring
    • 6.3.4 Others
  • 6.4 Ophthalmic Devices Market, By Product Type
    • 6.4.1 Diagnostic Devices
    • 6.4.2 Surgical Devices
    • 6.4.3 Vision Care Devices
    • 6.4.4 Other Devices

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Ophthalmic Devices Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Ophthalmic Devices market is categorized based on

By Product Type

• Diagnostic Devices
• Surgical Devices
• Vision Care Devices
• Other Devices

By Application

• Cataract Surgery
• Refractive Surgery
• Diagnostics & Monitoring
• Others

By End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Others

By Technology

• Femtosecond
• Excimer Lasers
• Optical Coherence Tomography
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Johnson & Johnson Vision Care
• Alcon Inc.
• Abbott Laboratories
• Bausch + Lomb
• Zeiss Group
• Hoya Corporation
• EssilorLuxottica
• Medtronic plc
• Topcon Corporation
• Shire plc
• CooperVision, Inc.
• Oculus Optikgerate GmbH
• Rayner Intraocular Lenses Limited
• Heidelberg Engineering GmbH
• Carl Zeiss AG